Thursday, October 4

16:30–17:30 Symposium 1 - supported by AstraZeneca and MSD

Exploring the role of PARP inhibitors in the management of ovarian cancer

16:30-16:50 Shining a light on the science behind PARP inhibition
Yves Pommier 

16:50-17:05 Integrating PARP inhibitors into clinical practice
Jonathan Ledermann 

17:05-17:30 What’s coming next? The future of PARP inhibitors in ovarian cancer
Isabelle Ray-Coquard

Friday, October 5

11:00–12:00 Symposium 2 - supported by Medtronic

Optimal Care of Endometrial Cancer: Are We Getting There?

11:00–11:10 Introduction by Chairman
Introduce speakers and the objective of this satellite symposium
Pierre Collinet

11:10–11:25 Perioperative management of patients with endometrial cancer
Karl Tamussino

11:25–11:40 Intra-operative management of patients with endometrial cancer
Pierre Collinet

11:40–11:55 Evidence Based Adjuvant Therapy: How to avoid overtreatment?
Frédéric Kridelka

11:55–12:00 Questions & Answers
All speakers

12:00–13:00 Symposium 3 - supported by Stryker

Novel surgical applications of ICG and NIR fluorescence imaging: An essential tool in the tool-box for the management of rare gynaecological tumours

12:00-13:00 Novel surgical applications of ICG and NIR fluorescence imaging: An essential tool in the tool-box for the management of rare gynaecological tumours
Raj Naik

16:00–17:00 Symposium 4 - supported by Tesaro

Spotlights on PARP inhibition in ovarian cancer management:
Experts’ insights discussion on choice and use of PARPi for safe and efficacious maintenance therapy in ovarian cancer

Chair: Isabelle Ray-Coquard

16:00-16:05 Welcome and introduction
Isabelle Ray-Coquard

16:05-16:15 What can PARP inhibition maintenance therapy offer to ovarian cancer patients?
Isabelle Ray-Coquard

16:15-16:55 Expert insights discussion
Moderator: Antonio González Martín
Panelists: Mansoor Raza Mirza, Ana Oaknin, Sandro Pignata, Isabelle Ray-Coquard, Jalid Sehouli

16:55-17:00 Summary
Antonio González Martín

17:00–17:30 Sponsored talk 1 - supported by PharmaMar

Sarcomas of the uterus
Isabelle Ray-Coquard

Saturday, October 6

09:30–10:00 Sponsored talk 2 - supported by Genmab

Transforming Treatment Paradigms in Metastatic Cervical Cancer
Reshma Rangwala

10:30–10:50 Sponsored talk 3 - supported by Clovis Oncology

Unmet medical needs in patients with relapsed ovarian cancer associated with and without BRCA mutations
Alexandra Leary